Corporate Banner
Satellite Banner
Technology Networks Header
Monday, July 28, 2014
Technology Networks
 
Register | Sign in
Home Page>Products
  Product News
Proteros and CHDI Establish Discovery Services Collaboration to Address Huntington’s Disease
Tuesday, March 22, 2011
Proteros entered into a service agreement with CHDI, under which Proteros will provide structure-based drug discovery services to CHDI.

Syrris Announces Exclusive Agreement to Offer Advanced Crystallization Control and Particle Engineering
Tuesday, March 22, 2011
Agreement with Prosonix to sell Atlas SonoLab SL10 sonocrystalizer extended.

Proteros and UC DDC Establish Collaboration to Offer High-Throughput Screening Services and Access to a 340,000+ Compound Library
Friday, March 11, 2011
Proteros will be responsible for all the client interactions and project management providing a single point of contact.

96 Well CrystalQuick X: Microplate Especially Suited for In-situ X-ray and UV Analysis of Protein Crystals
Tuesday, March 01, 2011
Greiner Bio-One’s 96 well CrystalQuick X plate is the first of its kind to be specifically tailored to the requirements of X-ray structure analysis of protein crystals directly in the plate.

Microplate for in-situ X-ray and UV Analysis of Protein Crystals
Tuesday, March 01, 2011
The 96 well CrystalQuick X plate microplate from Greiner Bio-One is the first of its kind to be specifically tailored to the requirements of X-ray structure analysis of protein crystals directly in the plate. It is also optimal for UV screening of crystals.

New Alignment Tool for Researchers
Tuesday, February 22, 2011
Mitegen LLC announces the release of the MicroRT™ Aligner, an alignment tool for researchers performing room and variable temperature diffraction.

Labcyte Introduces the Access™ Laboratory Workstation
Tuesday, February 01, 2011
The Access workstation takes the powerful suite of software applications and automation control proven successful on the POD™ 810 automation platform to the bench top.

How Size Exclusion Chromatography Illuminates Protein Crystallization
Tuesday, December 07, 2010
Understanding membrane protein crystallization is one of the main goals of molecular biology studies aimed at the structural characterization of proteins. A method capable of providing insight into the likelihood of crystallization of a sample and its protein content has been published as an application note by Malvern Instruments in conjunction with the Membrane Protein Laboratory at London’s Imperial College.

MiTeGen Announces New Tool for Low Disturbance Crystal Retrieval
Thursday, October 28, 2010
MiTeGen, LLC has introduced Microloops™ LD for protein crystal harvesting and X-ray data collection. Conventional loop mounts suck up liquid and crystals when they are inserted into protein drops, which makes harvesting the most promising crystals difficult.

<< 3 4 5 6 7 8 9 >>
Showing Results 51 - 60 of 231
Scientific News
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Shenogen and Chemizon Announce Drug Discovery Collaboration Focused on Oncology and Endocrine Disorders
The agreement will create small molecule therapeutics targeting modulators of the ER-alpha 36 receptor.
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Skyscraper Banner
Skyscraper Banner
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to LabTube.tv